Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists
Tanya Wilcox, Christophe De Block, Arthur Schwartzbard, Jonathan Newman
Topics & Concepts
MedicineMetforminDiabetes mellitusSulfonylureaType 2 diabetesType 2 Diabetes MellitusCardioprotectionSemaglutidePharmacologyDipeptidyl peptidase-4Adverse effectDiseaseLiraglutideInternal medicineEndocrinologyMyocardial infarctionDiabetes Treatment and ManagementPancreatic function and diabetesDiabetes Management and Research